期刊文献+

革兰阴性杆菌中超广谱β-内酰胺酶和AmpC酶的检测与分析 被引量:17

Detection and analysis of extended-spectrum β-lactamase and AmpC enzyme in Gram-negative bacteria
下载PDF
导出
摘要 目的 :了解革兰阴性杆菌中超广谱 β 内酰胺酶 (ESBLs)、AmpC酶的产生情况 ,为临床用药提供参考依据。方法 :用纸片扩散确证试验检测 3 4 5株革兰阴性杆菌的ESBLs产生情况 ,同时用酶提取物三维试验检测其中 194株菌的AmpC酶产生情况。结果 :革兰阴性杆菌中 ,ESBLs阳性率为 3 0 .4% ,主要产生菌为阴沟肠杆菌 68.2 % ,大肠埃希菌 45.9% ,肺炎克雷伯菌 3 1.0 % ;AmpC酶阳性率为 11.9% ,主要产生菌为阴沟肠杆菌 2 9.5% ,鲍曼不动杆菌 18.2 %。结论 :在革兰阴性杆菌中ESBLs、AmpC酶产生情况已相当严重和普遍 。 Objective: To investigate the production and distribution of extended-spectrum β-lactama se,AmpC enzyme in Gram-negative bacteria, and to provide references for the clinical application of drugs. Methods:ESBLs were detected against 345 strains by disc diffusi on confirmatory test,AmpC were detected against 194 strains by three dimensional test.Results:Among 345 strains,producing ESBLs bacteria accounted f o r 30.4%,of them Enterobacter cloacae, Escherichia coli, Klebsiella pneumoniae we re 68.2%,45.9% and 30.0% respectively;Among 194 strains producing AmpC enzyme ba cteria accounted for 11.9%(23/194),of them Enterobacter cloacae,Acinetobacter ba umannii were 29.5% and 18.2% respectively. Conclusion:The production situation of ESBLs and AmpC enzyme in the gram-negative ba cteria are considerably severe and prevalence and should be detected and treated carefully.
出处 《温州医学院学报》 CAS 2003年第6期386-388,共3页 Journal of Wenzhou Medical College
关键词 革兰阴性杆菌 超广谱Β-内酰胺酶 AMPC Β-内酰胺酶 gram-negative bacteria extended-spectrum β-lactamase AmpC β-lactamases
  • 相关文献

参考文献3

二级参考文献39

  • 1Bennett PM, Chopra I. Molecular basis of β-lactamase induction in bacteria[J]. Antimicrob Agents Chemother, 1993, 37(2): 153-158.
  • 2Sanders CC, Bradford PA, Ehrhardt AF et al. Penicillin-binding proteins and induction of AmpC β-lactamase[J]. Antimicrob Agents Chemother, 1997, 41(9): 2013-2015.
  • 3Jones RN. Important and emerging β-lactamase-mediated resistances in hospital-based pathogens: the AmpC enzymes[J]. Diagn Microbiol Infect Dis, 1998, 31(3): 461-446.
  • 4Haruta S, Nukaga M, Taniguchi K et al. Resistance to oxyimino β-lactams due to a mutation of chromosomal β-lactamase in Citrobacter freundii[J]. Microbiol Immuno, 1998, 42(3): 165-169.
  • 5Korfmann G, Sanders CC, Moland ES. Alterd phenotypes associated with ampD mutations in E. cloacae[J]. Antimicrob Agents Chemother, 1991, 35(2): 358-364.
  • 6Bartowsky E, Normark S. Purification and mutant analysis of Citrobacter freundii AmpR: the regulator for chromosomal AmpC β-lactamase[J]. Mol Microbiol, 1991,5(7): 1715-1725.
  • 7Stapleton P, Shannon K, Phillips I. DNA sequence differences of ampD mutants of Citrobacter freundii[J]. Antimicrob Agents Chemother, 1995, 39(11): 2494-2498.
  • 8Bush K , Jacoby GA, Mederios AA. A functional classification scheme for β-lactamases and its correlation with molecular structure[J]. Antimicrob Agents Chemother, 1995, 39(6): 1211-1233.
  • 9Papanicolaou GA, Mederios AA, Jacoby GA. Novel plasmid-mediatedβ-lactamase (MIR-1) conferring resistance to oxyimino-and α-methoxy β-lactams in clinical isolates of Klebsiella pneumoniae[J]. Antimicrob Agents Chemother, 1990, 34(11): 2200-2209.
  • 10Bauernfeind A, Chong Y, Schweighart S. Extended broad spectrum β-lactamases in Klebsiella pneumoniae including resistance to cephamycins[J]. Infection, 1989, 17(5): 316-321.

共引文献336

同被引文献111

引证文献17

二级引证文献63

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部